Chronic lymphocytic leukemia (CLL) is the most frequently occurring adult blood cancer in Western countries. The research conducted by Rachel Thijssen focuses on the signaling pathways that are important for the survival of CLL cells in the microenvironment and how the responsible signaling pathways can be inhibited. Insight into the signaling pathways is important for the development of new treatment strategies for CLL.
Mw. R. Thijssen: The Interplay between Microenvironmental Signaling and Novel Targeted Drugs in CLL
Promotoren zijn prof. dr. A.P. Kater en prof. dr. E.F. Eldering. Copromotor is prof. dr. M.J. Kersten.
Prof. A.P. Kater
Prof. E.F. Eldering
Prof. M.J. Kersten
Dr D.K. Kaawa-Mafigiri (Makerere University)
This event is open to the public.